Terminated NA INTERVENTIONAL 1-arm NCT03987672

Study to Intervene With Nutrition for Gastroparesis (SING)

Sponsor: Stanford University

Interventions Assess the nutritional effects of the Kate Farm Peptide 1.5 nutritional Formula

Updated 7 times since 2019 Last updated: Aug 18, 2022 Started: Aug 1, 2019 Primary completion: Aug 18, 2022 Completion: Aug 18, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Recruitment challenges

Other terminated trials from Stanford University

See all terminations from Stanford University

Other Gastroparesis trials with similar outcome

NCT02510976 · Phase PHASE4 · Jan 2021

Browse all Gastroparesis trials

This NA trial investigates Gastroparesis and is currently terminated or withdrawn. Stanford University leads this study, which shows 7 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Sep 2022 — Jul 2024 [monthly]

Terminated NA

Status: Recruiting → Terminated
Jan 2021 — Sep 2022 [monthly]

Recruiting NA
Sep 2020 — Jan 2021 [monthly]

Recruiting NA

▶ Show 2 earlier versions

Oct 2019 — Sep 2020 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Jul 2019 — Oct 2019 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Stanford University

Data source: Stanford University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Redwood City, United States